Saturday 4th February 2012
by adminFollowing the Depuy hip replacement recall, the US Food and Drug Administration (FDA) announced it was investigating concerns about metal-on-metal hip implants. The DePuy hip recall was announced soon after research showed a greater than expected failure rate. Portion of the dilemma with the DePuy hip replacement was that debris from the metal-on-metal DePuy hip was released into patients’ bloodstreams, potentially causing metallosis and failure of the hip.
According to the FDA, the agency was “actively working in many areas to further assess the safety and effectiveness” of the metal-on-metal devices. Traditionally, hip replacement devices contain a ceramic or polyethylene component. Some latest hip replacements, even so, replaced the ceramic with metal, saying that the metal is a lot more durable and perfect for younger patients who are much more active. In addition, the metal-on-metal devices are believed to have a decreased possibility of dislocation and a decreased likelihood of device fracture.
The issue with metal-on-metal devices was that debris can come loose and be absorbed into the patient’s bloodstream, resulting in high metal-ion levels. Complicating matters is that reactions to the metal ions vary for each patient.
“Distinct individuals will react to these metal particles in different methods,” the FDA notes. “At this time, it is not feasible to know who will experience a reaction, what type of reaction they may well have, when the reaction will occur or how severe the reaction will be. Even so, it was recognized that over time, the metal particles about some implants can trigger harm to bone and/or tissue surrounding the implant and joint.” If you or someone you know have suffered due to a Depuy Hip replacement then you may want to file a Depuy Hip lawsuit.
Patients who knowledge harm to the tissue and/or bone could suffer pain and may experience loosening of the device. In such circumstances, the patient may require revision surgery to remove and replace the device.
The FDA further notes that some patients who had high levels of metal ions in their bloodstream seasoned symptoms or illness in other parts of their body, including their heart and nervous technique.
Signs that a hip replacement device is failing incorporate discomfort in the groin, hip or leg swelling at or close to the hip joint and a adjust in walking potential. Other symptoms of issues related to metal ions in the blood stream consist of a adjust in common well being, chest discomfort, shortness of breath, numbness, weakness and alter in urination habits.
The FDA recommends that surgeons not use all-metal implants in patients who have metal sensitivity or a suppressed immune program. Meanwhile, the agency has requested that manufacturers send analyses of hip replacement parts that are retrieved from patients. The FDA also published a series of Web pages regarding metal-on-metal hip implants. For more information you can also speak with a Depuy Hip lawyer.